PLEASANTON, CA.—10x Genomics, a company focused on accelerating genomic discovery, today announced that it had raised $125 million in funding. The funding included a $50 million Series D financing. It was led by Meritech Capital Partners and included new investor Wells Fargo Strategic Capital along with current investors Paladin Capital, Fidelity and the SoftBank Group. […]

Project will increase capacity to meet growing customer demand  ST. LOUIS — Thermo Fisher Scientific announced today that is investing $50 million in its St. Louis, Missouri site which is one of the company’s Centers of Excellence (COE) for Biological Commercial Manufacturing. The investment is part of a deliberate strategy to continue expansion of the company’s global network of biologic drug […]

£57.5k investment for quick, simple food safety tests using nanoparticles and antibodies Glasgow – The Industrial Biotechnology Innovation Centre (IBioIC) today announces funding of £57,500 to investigate a new technique to model antibodies bound to gold nanoparticles, allowing production of tests that are of a higher accuracy and reduced manufacture cost, which could be used to […]

Tokyo, Japan – Hitachi High-Technologies Corporation (TSE:8036, Hitachi High-Tech) announced Hitachi High-Tech’ s capital participation in OmniSeq®,Inc. (OmniSeq), which is a molecular diagnostics subsidiary of the Roswell Park Comprehensive Cancer Center, which was the first institution to focus exclusively on cancer research. Hitachi High-Tech has made the field of biotechnology and healthcare its priority. Amid […]

Global leader in organ-on-a-chip technology backed by international syndicate for worldwide commercial expansion and new product development Leiden, the Netherlands — MIMETAS, leader in organ-on-a-chip products and tissue models, has secured 20.5 million USD in financing from an international syndicate from Asia and Europe. MIMETAS will use the proceeds of this Series B financing round to expand […]

UTRECHT, THE NETHERLANDS MILabs B.V. reported that for the third year in a row, the rapidly-innovating molecular imaging company has continued on its trajectory of strong preclinical imaging systems sales with another year-to-year rise close to 50%. “The dramatic increase in sales validates the design and functionality of our multimodal imaging platform and confirms that it enables […]

New grants will accelerate DNA Script’s commercialization of its novel high speed, high efficiency, free-of-harsh-chemicals DNA synthesis technology. Paris, France – DNA Script today announced awards totaling $5.5M in non-dilutive financing from the highly selective Horizon 2020 European Innovation Council program of the European Commission and the Aide au développement de l’innovation and Concours Mondial d’innovation programs of Bpifrance. DNA Script […]

Connection Capital, the specialist private client investment business, has raised £5.9m from its private investor clients to invest in a specialist laboratory equipment manufacturer with a global blue chip client base. HEL Ltd (HEL) designs and supplies a range of custom-made modular lab instruments and testing equipment. Typical products include different forms of “reaction stations” […]

SAN FRANCISCO, Calif. – Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the completion of a private placement of $50 million, bringing the total raised to $259 million since the company’s founding in 2013. “We have used our proprietary DNA synthesis platform, which delivers precision at […]

Exclusive two-way licensing deal promises to accelerate growth for both companies Frederick, MD — Akonni Biosystems Inc. and Chinese in vitro diagnostics company, Righton, announce a commercial agreement that enables Righton to sell Akonni’s products for nucleic acid purification and molecular diagnostics to reaserchers, clinical laboratories, and hospitals in China. The products to be sold include TruTip®, Akonni’s best-in-class […]